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Acetylcholme stimulation of the m3 or m2 muscarinic receptor expressed in Xenopus lurris oocytes Induces either a fast transient or slowly oscillating 
calcmm-sensitive chloride current. The speed of these currents reflects the efficiency of receptor coupling to guanine nucleotide-bmding proteins 
and phosphatidylinositol (PI) turnover. Point mutations of the m3 receptor were made in a region of the third cytoplasmic loop to test whether 
receptor function relied on an a-helical structure of the G protein-coupling domain. Prolme substitution for glutamate at position 257 disrupted 
the m3 response. Also, smgle alanine msertions between residues 259 and 260 disrupted the m3 receptor-stimulated response while double alanme 
insertions at this site had no effect. Based on these results, we suggest that a region of the third cytoplasmic loop of the m3 receptor possesses an 
amphipathic a-helical conformation. 
Xenopus oocyte; G protem-coupling. Amphipathic a-helix; Seven transmembrane-spannmg receptors, Mastoparan 
1. INTRODUCTION 
mAChRs are central to the regulation of many cellu- 
lar responses including smooth muscle tone, heart rate, 
secretion, synaptic transmission, neuronal excitability, 
cognition and memory [l]. Genomic cloning revealed 
there are at least five distinct human gene sequences for 
the mAChR designated as subtypes ml-m5* [2-51. Bio- 
chemically, the mAChR subtypes belong to one of two 
classes. Subtypes ml, m3 and m.5 stimulate turnover of 
PIP-,. liberating the intracellular second messengers 
Ins( 1,4S)P, and diacylglycerol [6]. Ins( 1,4,5)P, triggers 
the release of Ca”’ from intracellular stores while dia- 
cylglycerol stimulates protein kinase C activity [7]. Re- 
ceptor subtypes m2 and m4 inhibit adenylyl cyclase and 
weakly stimulate PIP1 turnover [8810]. These biochemi- 
cal systems are a feature shared by many neu- 
rohormonal cell membrane receptors which effect signal 
transduction by stimulating, in a very specific fashion, 
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a family of heterotrimeric G proteins [ll]. A central 
question of signal transduction for neurohormonal 
agents is the molecular mechanisms regulating the re- 
ceptor’s specificity for these different G proteins. Struc- 
tural analysis of the mAChRs indicate that they have a 
hydropathic profile similar to that of other G protein- 
linked receptors, identifying them as a member of this 
superfamily [3]. Inference from the crystal structure of 
bacteriorhodopsin, which possesses a hydropathic pro- 
file similar to this receptor superfamily, predicts that the 
mAChRs have seven transmembrane-spanning regions 
connected by three extracellular and three cytoplasmic 
loops. Previous studies have implicated numerous cyto- 
plasmic regions as contributing to G protein coupling 
for different G protein-linked receptors [12]. However, 
the precise molecular details of the interaction between 
these receptors and their G proteins is not clear, pre- 
venting a complete understanding of the mechanisms 
regulating signal transduction for hormones and neuro- 
transmitters. 
In order to study cell membrane receptors regulating 
Ins( 1,4,5)P, production and intracellular Ca” release 
on a fast time scale. Lechleiter et al. [9] employed tran- 
sient expression of exogenous membrane proteins in 
Xenopus oocytes. The endogenous Icd_,-, in these oocytes 
is easily measured and provides a sensitive indicator of 
Ins( 1,4,5)P, production. For example, following stimu- 
lation of Xenopus oocytes expressing the m3 AChR, a 
fast transient Z,--_C, was observed [9]. 96% of these desen- 
sitizing (Dl type; [9,13]) currents peaked within the first 
20 s of receptor stimulation (n = 454). Muscarinic re- 
ceptor subtype 2 (m2) evoked currents which displayed 
*Subtypes of the mAChR are designated as ml, m2, m3. m4 and m5 
as defined by the Fourth International Symposium on Subtypes of 
Muscarimc Receptors. 
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a clearly different profile. Oocytes expressing the m2 
AChR generally exhibited a slowly developing and fluc- 
tuating (f type: [ 131) current. 72% of which peaked be- 
tween 20 and 120 s (n = 451: [9]). The distinct kinetics 
of the Dl and the f type currents are thought to repre- 
sent separate transduction pathways for Ins( 1.4,5)P, re- 
lease. Dual pathways are supported by several lines of 
evidence. For example. comparable levels of expression 
and agonist binding behavior were observed for these 
mAChRs in eukaryotic cells suggesting that the differ- 
ent kinetic profiles for the currents were not due to 
differences in receptor expression. The independence of 
the latency-to-peak current as a function of Icd_c, ampli- 
tude and the differential sensitivity of the Dl and f 
currents in oocytes to inhibition by pertussis toxin 
(PTX) further support dual signalling pathways. To ad- 
dress the question of which cytoplasmic domains of the 
receptor specify the type of G protein activated. Lechle- 
iter et al. [9] assayed several m2/m3 chimeric receptors 
and characterized their responses according to the cur- 
rents that they evoked. Their results indicated that a 
major determinant of receptor-G protein coupling was 
localized to the amino terminus of the third cytoplasmic 
loop [9]. Contrary to what has been observed for several 
G protein-linked receptors. other regions, such as the 
carboxy terminus of the third cytoplasmic loop or the 
carboxy tail of the mAChR, to date. have not been 
implicated in the initial response ([9] and unpublished 
results). The structural requirements relating to recep- 
tor function, however, are unknown. 
Recently, it was reported that several amphipathic 
a-helical peptides could stimulate G proteins [14]. Most 
notably. the tetradecapeptide wasp venom. masto- 
paran, stimulated in vitro GTP binding and hydrolysis 
with a variety of purified G proteins. It is well estab- 
lished that amphipathic cr-helical motifs frequently reg- 
ulate protein-protein interactions [15]. Comparison of 
the G protein activating potential of mastoparans [14] 
to membrane-associated cell signalling suggest that cy- 
toplasmic regions of the Ins( 1,4,5)P,-linked receptors 
regulating G protein activation might possess a-helical 
properties as predicted from various protein secondary 
structure algorithms [9.16,17]. The following report ex- 
amines this hypothesis by placing point mutations in 
key sites of the G protein interactive domain of the m3 
receptor and assaying for production of either the Dl 
or f type currents. 
2. MATERIALS AND METHODS 
Plasmids containing the cloned human m3 and mZ AChR [3]. were 
used for productton of mRNA usmg a standard SP6 driven m vitro 
transcriptton protocol [18]. Point mutants of the human m3 receptor 
were made usmg ohgonucleottde-directed mutagenests techmques [19]. 
Mutated phagemtd constructs were verttied by DNA cham termina- 
tion sequencing [20]. 
Techniques for mjectmg and recording from oocytes were reported 
previously [9] Briefly. oocytes were defolhculated to reduce en- 
dogenous ACh responses and subsequently Injected with approxi- 
mately 50 ng of mRNA. m2. m3 AChR mRNA- or deiomred H,O- 
injected oocytes were exammed in parallel with mutant receptor 
mRNA to control for oocyte vat-lability m current responses. Injected 
oocytes were stored overnight in L-15 supplemented medium, changed 
dally. Current measurements aere performed 2 days post-mjection. 
Currents were evoked following addition of 50pM ACh to the media 
(Barth’s) bathing aocytea and voltage-clamped at a holding potenttal 
of -70 mV. 
Infrequently, ACh sttmulatton of mRNA-Injected oocytes evoked 
either small or no Ic,.c,. Because of H,O-injected oocytes often times 
would evoke small amplitude currents tt was dtfhcult to establish 
whether currents below 100 nA were due to the expresston of injected 
mRNA or due to endogenous mechamsms for evoking Ica_c,. There- 
fore. only those mRNA-injected oocytes evoking peak currents 
greater than 100 nA were retained for comparison. Thts resulted in the 
exclusion of a small number of measurements (excluded/total: m3: 
1139: m?: 4132: E257P: 7137; T258P: O/45, E257A O/18; EK259EAK - 
l/18: and EK259EMK: O/19). 
3. RESULTS 
Stimulation of m3 receptors expressed in Xenopus 
oocytes with a saturating concentration of acetylcholine 
(ACh. 50 PM) uniformly produced a large desensitizing 
(Dl type) current (4,700 ? 600 nA, S.E.M.; Fig. 2). 
These oocytes attained a peak current rapidly (2 + 1 s, 
S.E.M.) with a near complete return to baseline within 
20 s in 32 of 37 oocytes. Stimulation of m2-expressing 
oocytes, however. evoked slowly developing fluctuating 
(f type) currents peaking between 20 and 120 s in 22 of 
28 oocytes. The average latency to peak current in these 
oocytes was significantly longer than observed with 
stimulation of m3 AChRs (56 2 12 s, S.E.M.: Fig. 3). 
All mRNA-injected oocytes responses were compared 
to H,O-injected oocytes to control for endogenous ACh 
responses (see section 2). The H,O-injected oocytes re- 
sponded poorly to ACh, generally evoking either a 
small or no f type current (average peak Zc+c, < 100 nA, 
12 = 28). Since Ica_c, recordings provided a high time 
resolution (ms) measure of changes in intracellular cal- 
cium concentrations [lo]. which correlated well with 
Ins(l,4,5)P, production [8.21]. the Dl and f type cur- 
rents were used to assay for G protein coupling-ability 
of mutant m3 receptors. 
Variants of the m3 AChR. containing mutations in 
a region of the receptor known to regulate coupling to 
G proteins, were assayed for their ability to preserve or 
alter the normal signal transduction pathways. These 
mutants involved either substitution of residues with 
proline. in order to interrupt putative or-helical struc- 
ture, or insertions of alanine. designed to disrupt the 
spatial distribution of charges around a helix, ACh 
stimulation of a proline-substituted mutant m3 AChR, 
T258P (Fig. 1 ), evoked a fast transient current resem- 
bling the Dl type current (Fig. 2). In spite of the gener- 
ally lower current amplitude for mutant T258P. perhaps 
due to decreased receptor expression or less effective PI 
coupling, 38 of 45 oocytes exhibited current peaks dur- 
ing the initial 20 s (17 f 4 s). Proline did not alter the 
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Fig. 1. Structural models of parental and mutated mAChRs. Putative transmembrane models for the m2 and m3 muscarinic receptor subtypes are 
tllustrated (top). The greatest heterogeneity across the mAChR famtly is found at the ammo termmus. the large thud cytoplasmic loop and the 
carboxy terminus [3]. A region of the m3 receptor known to mediate receptor--G protein couplmg, as well as the posmon and corrected ammo 
acid sequence of several pomt mutants, is shown on an expanded scale. lndtvidual restdues are represented by the one letter amino acid code Dashes 
indicate ammo acids identtcal to the corresponding position of the m3 receptor. Verttcal dashed line represents the transition from the fifth 
transmembrane-spanning segment to the thnd cytoplasmic loop. 
kinetic profile of the m3 AChR-mediated response 
when substituted at this position. Substitution of pro- 
line for glutamic acid at the adjacent residue, E257P 
(Fig. 1). however, resulted in agonist-evoked f type cur- 
rents (Fig. 2). Of 30 oocytes expressing mutant E257P. 
25 peaked later than 20 s (73 + 7 s, S.E.M.). An alanine- 
substituted mutant, E257A (Fig. 1 ), was assayed to test 
whether the presence of a negatively charged amino acid 
at this glutamic acid residue was critical to development 
of the Dl type current. Receptor activation of E257A 
consistently evoked the Dl type response in 18 oocytes 
(2 & 1 s, S.E.M.; Fig. 2). Thus, there is a marked con- 
trast in the response between substitution of an alanine 
and a proline at residue 257. The Dl type response 
elicited by stimulation of E257A indicates that the loss 
of the negatively charged glutamate along cannot ac- 
count for the disruption of the Dl type current exhibited 
by E257P. 
We designed and assayed several insertional mutants 
which were predicted to distort any amphipathic a-hel- 
ical character for the amino terminal region of the third 
cytoplasmic loop (Fig. 1). Of the naturally occurring 
amino acids, alanine insertions are energetically the 
most compatible to a-helical formation [22,23]. There- 
fore, insertion of an alanine would be expected to influ- 
ence the hydrophobic/amphipathic nature for this re- 
gion of the receptor while preserving its a-helical struc- 
ture. Twelve of 17 oocytes expressing the alanine inser- 
tional mutant EK259EA_K (Fig. 1) exhibited f type cur- 
rents (57 + 10 s. S.E.M.; Fig. 2B). It is unlikely that 
EK259EAK failed to evoke the Dl type current due - 
simply to an extended primary structure for this region 
of the receptor since a double alanine insertional mu- 
tant, EK259E&K (Fig. 1). resulted in the Dl type 
current. Sixteen of 19 EK259EAAK expressing oocytes 
responding within the first 20 s of ACh exposure (15 +_ 5 s, 
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rtg. L. rarental and mutant mAChR demonstrate dtsttnct Ca”-acttvated chlorrde currents (f, a~< ,) m .Yenoru.v oocytes (A) Representatrve current 
waveforms are shown for the m3, m2 and mutated m3 receptors Smgle amino acid substttuttons were made at etther glutamate (E) 257 or at 
threonine (T) 258. An additional pair of mutants contaming single or double alanine (A) inserttons followmg glutamate (E) 259 were also exammed 
(see Fig. 1). 50,~M ACh was added at the arrow. The fast transtent (Dl) current followmg sttmulatton of the m3 receptor IS dtfferentially sensrtive 
to mutations of the m3 receptor at the mdtcated resrdues (see also text). (B) The latency to peak and maxtmum amphtudes are drsplayed for the 
currents from individual receptor-ewpressmg oocytes (see mset at right). The shaded regron between 0 and 20 s represents the pertod containmg 
96% of the peak amplitudes for the m3-strmulated Dl currents [9]. The average & S.E.M for both measurements IS Indicated by a box 
S.E.M.; Fig. 2B). These results are evaluated below in 
the context of the spatial positioning of amino acids in 
an a-helical model. 
4. DISCUSSION 
The amino terminus of the third cytoplasmic loop of 
the mAChR is recognized as the major determinant 
specifying coupling between these receptors and G pro- 
teins [9.24]. When expressed in Xenopus oocytes. the m3 
and m3 AChR elicit a Dl or f current. respectively. 
Similar characteristic kinetic profiles were also observed 
for several mAChR variants containing mutations of 
the third cytoplasmic loop [9]. The ability to elicit a 
unique pattern of Ica_c, in oocytes for these mAChRs, 
which exhibit comparable receptor expression and ag- 
onist binding behavior in eukaryotic cells, supports a 
role for dual signalling pathways in evoking either the 
Dl or f currents [9]. We have used this system, there- 
fore, to test whether the efficacy of G protein-coupling 
to m2 receptors requires an amphipathic a-helix in this 
region of the receptor. 
A marked difference was observed between proline 
substitution at adjacent amino acid residues (E257P vs 
T258P; Fig. 1). Although agonist stimulation of the 
106 
distally located substitution mutant, T258P. resulted in 
Dl type current. a more membrane proximally located 
mutation, E257P, produced a nondesensitizing f type 
current. The inability of the latter to signal to the Dl 
pathway cannot result from changes in the receptor’s 
electrostatic properties since alanine substitution at the 
same position (E257A) also elicited Dl type currents. 
Proline is energetically incompatible with a-helices 
[22,23,25.26] and we interpret these results as evidence 
of the conformationally induced inability of E257P to 
interact with the G protein normally associated with the 
m3 AChR. However. this interpretation is probably a 
simplification given the ability of T258P to elicit the Dl 
type currents. Examination of m2/m3 AChR chimeras 
suggested that amino acids proximal to the fifth trans- 
membrane segment (Arg-Iso-Tyr-Lys: RIYK) partly 
specify the coupling of m3 receptors to G proteins (com- 
pare HY 12 and 32, [9]) but the exact residue(s) defining 
this G protein-coupling region are uncertain. Our re- 
sults indicate that proline substitution immediately ad- 
jacent to amino acids RIYK has a greater disruptive 
influence on the m3 receptor-G protein signalling path- 
way than at the more distally located threonine. 
Alanine insertional mutants were assayed to test 
whether the amphipathic nature of the or-helix influ- 
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enced receptor-G protein coupling. Helical wheel mod- 
els for m3 and the insertional mutant receptors demon- 
strated varying degrees of charge separation (Fig. 3). 
Mutant EK259EAK exhibits no distinct amphipathic 
character and we believe that this property is reflected 
in the f type currents elicited by this mutant. Modeling 
of mutant EK259EAAK, which elicited the D 1 currents 
representative of a normal signalling pathway, shows a 
separation of charged surfaces intermediate between 
that of EK259EAK and the m3 AChR. A correlation 
between the amphipathic character for this region of the 
m3 receptor variants and their ability to mimic the nor- 
mal receptor-G protein signalling is further strength- 
ened by two points. First, the terminal amino charge of 
lysine (K) is separated from the peptide backbone by a 
4 hydrophobic methylene groups. These flexible linkers 
may permit a partial dispersion of the terminal amino 
charge for those lysines bordering the hydrophobic sur- 
face in our model [22]. This property results in a less 
dramatic intrusion of those charges defining the bound- 
ary between the charged and uncharged surfaces and, 
therefore, a more definite amphipathic characterization. 
Second, the region containing these charges is several 
turns of the a-helix distal to RIYK, which is reported 
to participate in G protein coupling (see above). Re- 
gions located distal to this site, therefore, may mini- 
mally influence protein-protein interactions occurring 
at these residues simply by nature of their displacement 
along the axis. 
Attempts to explain the results of the insertional mu- 
tants based on a model of linear displacement of the 
primary structure simply would not be consistent with 
the observed recordings. Although such a model might 
be reflected in the disruption of the receptor-G protein 
interaction generating the Dl currents, as exhibited by 
mutant EK259E_AK, it is clearly inappropriate to ex- 
plain the unaltered current kinetics elicited by mutant 
EK259EAAK (Fig. 2). - 
Although it is clear that only structural data, such as 
X-ray diffraction of the receptor-G protein complex, 
can determine which regions are directly involved in 
protein-protein interactions, site-directed mutagenesis 
m3 EK259EAK EK259EM_K MASTOPARAN 
Fig. 3. Helical wheel models representmg the amino termmus of the third cytoplasmic loop for the m3 and msertional mutant receptors. Individual 
residues are represented by the one letter amino acid code. The posttively charged arginine. seen at the top of the helix in the three dimensional 
model, is the putative first amino acid following the fifth transmembrane-spannmg segment, The darkly shaded regions (second row) indicate 
surfaces composed of uncharged amino acid residues, A clear charge separation is exhibtted in the model for the m3 receptor. Modeling for the 
double alanine msertional mutant EK259EAAK indicates that it is mtermediately amphtpathic (see text for details). Mutant EK259EAAK contains - 
a glutamate (E) and an argmine (R) Imposed on the uncharged surface of the wild type receptor resulting in an even less well defined charge 
separation. The G,-sttmulating amphipathic peptide mastoparan is shown on the right for comparison. The separation of charged and uncharged 
surfaces is also indicated by a dashed line in the 2 dimensional helical wheel models in the first row. 
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provides important information on the functional con- 
sequences of receptor alterations. Our results presented 
here support the simple hypothesis that the amphipathic 
a-helical structure of the amino terminal region of the 
third cytoplasmic loop is a critical determinant for G 
protein coupling by the m3 AChR. 
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